Tekla Healthcare Opportunities Fund Current Valuation
| THQ Fund | USD 20.30 0.47 2.37% |
Valuation analysis of Tekla Healthcare Opp helps investors to measure Tekla Healthcare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Tekla Healthcare's price fluctuation is very steady at this time. At this time, the fund appears to be fairly valued. Tekla Healthcare Opp has a current Real Value of $20.36 per share. The regular price of the fund is $20.3. We determine the value of Tekla Healthcare Opp from inspecting fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we recommend buying undervalued funds and selling overvalued funds since, at some point, fund prices and their ongoing real values will draw towards each other.
Tekla Healthcare's intrinsic value may or may not be the same as its current market price of 20.30, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 20.3 | Real 20.36 | Hype 20.24 | Naive 19.97 |
The intrinsic value of Tekla Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Tekla Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Tekla Healthcare Opportunities helps investors to forecast how Tekla fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tekla Healthcare more accurately as focusing exclusively on Tekla Healthcare's fundamentals will not take into account other important factors: Tekla Healthcare Opportunities Fund Current Valuation Analysis
Tekla Healthcare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Tekla Healthcare Opportunities has a Current Valuation of 0.0. This indicator is about the same for the Financial Services average (which is currently at 0.0) family and about the same as Asset Management (which currently averages 0.0) category. This indicator is about the same for all United States funds average (which is currently at 0.0).
Tekla Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tekla Healthcare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the funds which would be a good addition to a portfolio. Peer analysis of Tekla Healthcare could also be used in its relative valuation, which is a method of valuing Tekla Healthcare by comparing valuation metrics of similar companies.Tekla Healthcare is currently under evaluation in current valuation among similar funds.
Tekla Fundamentals
| Shares Outstanding | 41.34 M | ||||
| Shares Owned By Institutions | 19.54 % | ||||
| Number Of Shares Shorted | 14.15 K | ||||
| Price To Earning | 6.76 X | ||||
| Short Ratio | 0.14 X | ||||
| Earnings Per Share | 2.71 X | ||||
| Beta | 0.9 | ||||
| Market Capitalization | 951.66 M | ||||
| Annual Yield | 0.01 % | ||||
| Year To Date Return | 7.75 % | ||||
| One Year Return | 14.65 % | ||||
| Three Year Return | 2.65 % | ||||
| Five Year Return | 7.91 % | ||||
| Last Dividend Paid | 1.35 |
About Tekla Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tekla Healthcare Opportunities's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tekla Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tekla Healthcare Opportunities based on its fundamental data. In general, a quantitative approach, as applied to this fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Tekla Healthcare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tekla Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tekla Healthcare will appreciate offsetting losses from the drop in the long position's value.Moving against Tekla Fund
| 0.52 | FTCAX | Templeton Strained Bond | PairCorr |
| 0.37 | PYARX | Payden Absolute Return | PairCorr |
| 0.37 | LTFOX | Lord Abbett Affiliated | PairCorr |
| 0.37 | GAB | Gabelli Equity Trust | PairCorr |
| 0.34 | PYAIX | Payden Absolute Return | PairCorr |
The ability to find closely correlated positions to Tekla Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tekla Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tekla Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tekla Healthcare Opportunities to buy it.
The correlation of Tekla Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tekla Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tekla Healthcare Opp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tekla Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Tekla Fund
Tekla Healthcare financial ratios help investors to determine whether Tekla Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tekla with respect to the benefits of owning Tekla Healthcare security.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |